Shareprice
01 Dec 2023

Press & news

FluoGuide develops surgical solutions that are expected to reduce suffering for the patient and increase the likelihood of cure as well as reducing costs for the health care system.

New - New exchange: Nasdaq First North

FluoGuide is moving from Spotlight to Nasdaq First North. Shareholders are strongly encouraged to make sure they will be able to freely trade their shares in the future.

2023

21 March, 2023 FluoGuide awarded prestigious grant together with two academic partners News Corporate Information Other Corporate Information English Regulatory MAR IR
FluoGuide A/S (“FluoGuide” or the “Company”) is pleased to announce that Innovation Fund Denmark (Innovationsfonden)...
21 March, 2023 Minutes from Annual General Meeting in FluoGuide A/S News Corporate Information General meeting Report of the AGM English Regulatory Listing Regulation IR
Copenhagen, Denmark, 21 March 2023 – FluoGuide A/S (“FluoGuide” or the “Company”) held its annual general...
6 March, 2023 Notice of Annual General Meeting in FluoGuide A/S News Corporate Information General meeting Notice English Regulatory Listing Regulation IR
The board of directors hereby convenes the Annual General Meeting of FluoGuide A/S, company registration (CVR) no. 39 29 64 38 (the...
28 February, 2023 FluoGuide A/S publishes Year-end and annual report for the fiscal year 2022 News English Regulatory Listing Regulation Report Annual IR
27 February, 2023 FluoGuide updates on recruitment in phase IIb aggressive brain cancer trial with FG001 News Corporate Information Other Corporate Information English IR
FluoGuide A/S (“FluoGuide” or the “Company”) provides an update on the clinical timelines for the ongoing clinical...
2 February, 2023 FluoGuide appoints Ole Larsen as CFO News Corporate Information Other Corporate Information English Regulatory Listing Regulation IR
FluoGuide A/S (“FluoGuide” or the “Company”) has appointed Ole Larsen as Chief Financial Officer (“CFO”)...
25 January, 2023 CFO acquired shares in FluoGuide News Corporate Information Other Corporate Information English IR
FluoGuide A/S (“FluoGuide” or the “Company”) announce that the CFO of FluoGuide, Henrik Hang, has acquired...
9 January, 2023 FluoGuide releases positive interim result of FG001 in head and neck cancer News Corporate Information Other Corporate Information English Regulatory MAR IR
Copenhagen, Denmark, 9 January 2023 - FluoGuide A/S ("FluoGuide" or the "Company") is pleased to announce the positive...

2022

24 November, 2022 FluoGuide A/S publishes interim report for the period January – September 2022 News English Regulatory Listing Regulation Report Interim Q3 IR
In Q3 2022, FluoGuide made important progress and received approvals from Danish authorities to initiate the clinical phase IIb trial...

Calendar &
upcoming reports


29 November 2023

Interim report Q3, 2023


8-10 January 2024

SEB Nordic Seminar


31 January 2024

Økonomisk Ugebrev Life Science Investor Conference


28 February 2024

Year end report 2023

Show all posts